Skip to main content
WHANIN PHARM CO.,LTD logo

WHANIN PHARM CO.,LTD — Investor Relations & Filings

Ticker · 016580 ISIN · KR7016580003 KO Manufacturing
Filings indexed 179 across all filing types
Latest filing 2020-03-12 Audit Report / Informat…
Country KR South Korea
Listing KO 016580

About WHANIN PHARM CO.,LTD

https://www.whanin.com/?lang=eng

WHANIN PHARM CO.,LTD. is a pharmaceutical company that develops, manufactures, and sells a range of therapeutic products. The company specializes in medications for the Central Nervous System (CNS), with a particular focus on neuropsychiatric treatments such as anti-psychotics and CNS stimulants. In addition to its core CNS portfolio, Whanin Pharm's product line includes pharmaceuticals for the cardiovascular and gastrointestinal systems, antibiotics, and vitamin supplements. The company also provides development and manufacturing services for finished drug formulations.

Recent filings

Filing Released Lang Actions
감사보고서제출
Audit Report / Information Classification · 98% confidence The document is a regulatory filing titled 'Audit Report Submission' (감사보고서 제출) from Hwanin Pharmaceutical. It provides a summary of audit opinions, financial highlights (assets, liabilities, equity, profit/loss), and auditor information. While it contains financial data, it is a short, standardized regulatory announcement (under 5,000 characters) notifying the market that the audit report has been submitted, rather than the full, multi-page annual report document itself. Therefore, it falls under the category of a Report Publication Announcement (RPA). FY 2019
2020-03-12 Korean
주주총회소집공고
AGM Information Classification · 100% confidence The document is a 'Notice of Annual General Meeting' (주주총회소집공고) for Whanin Pharmaceutical Co., Ltd. It contains the meeting agenda, financial statements (balance sheet, income statement), and management's discussion of business operations. This type of document is standard for providing shareholders with the necessary information to vote at an AGM. According to the filing definitions, materials shared for an AGM are classified as AGM-R.
2020-03-04 Korean
주주총회집중일개최사유신고
AGM Information Classification · 95% confidence The document is a formal regulatory filing submitted to the Korea Exchange (KRX) regarding the 'Reason for holding a General Meeting of Shareholders on a concentrated date'. It explains why the company scheduled its AGM on a date that coincides with many other companies' meetings. Since this is a regulatory disclosure regarding meeting logistics rather than the meeting materials themselves (AGM-R) or a proxy statement (PSI), it falls under the general regulatory filing category.
2020-03-04 Korean
주주총회소집결의
AGM Information Classification · 98% confidence The document is a formal notice of a General Meeting of Shareholders (주주총회소집결의) issued by Whanin Pharmaceutical. It outlines the date, location, and agenda items (such as financial statement approval, director appointments, and articles of incorporation changes) for the upcoming meeting. This type of document is a standard proxy solicitation or notice of meeting, which falls under the 'Proxy Solicitation & Information Statement' category.
2020-02-20 Korean
현금ㆍ현물배당결정
Notice of Dividend Amount Classification · 100% confidence The document is a formal announcement from Hwanin Pharmaceutical regarding the decision to pay cash dividends. It specifies the dividend amount per share, the total dividend amount, the record date, and the date of the board resolution. This fits the definition of a 'Notice of Dividend Amount' (DIV).
2020-02-20 Korean
연결재무제표기준영업(잠정)실적(공정공시)
Earnings Release Classification · 100% confidence The document is a 'Preliminary Earnings Release' (영업(잠정)실적) for Hwanin Pharmaceutical. It provides key financial highlights such as revenue, operating profit, and net income for the 4th quarter of 2019 compared to previous periods. It is a concise summary of financial performance, not a full annual report or a transcript, fitting the definition of an Earnings Release (ER). Q4 2019
2020-02-11 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.